Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia
This AstraZeneca-sponsored clinical trial assesses chemo-radiation therapy patterns and short-term outcomes in routine practice for unresect…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid Tumors [Phase 2]
Phase 2 clinical trial update for BL-B01D1 in combination with a PD-1 monoclonal antibody in locally advanced or metastatic non-small cell l…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Adagrasib in Patients With KRASG12C-mutant NSCLC Who Are Elderly or Have Poor Performance Status [Phase 2]
Phase 2 study evaluating adagrasib in KRAS G12C-mutant non-small cell lung cancer patients who are elderly or have poor performance status; …
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study in Non-Small Cell Lung Cancer
A clinical trial in non-small cell lung cancer sponsored by N-Power Medicine is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating Quaratusugene Ozeplasmid (Reqorsa) in combination with Osimertinib for advanced non-small cell l…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Savolitinib Combine With Durvalumab in EGFR Wild-type Locally Advanced or Metastatic NSCLC [Phase 2]
This clinical trial update reports a Phase 2 study evaluating the combination of savolitinib with durvalumab in EGFR wild-type locally advan…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study to Compare Tissue and Liquid Biopsies in People With Different Types of Cancer [NA]
This Boehringer Ingelheim-sponsored trial compares tissue and liquid biopsies across multiple cancers—non-small cell lung cancer, colorectal…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: A Study of Vebreltinib and Platinum-Containing Double Agents in Subjects With MET-Positive [Phase 3]
A Phase 3 clinical trial evaluating Vebreltinib in combination with platinum-containing regimens in MET-positive non-small cell lung cancer,…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: LUNG-05: Investigating Chemotherapy Effectiveness for Non-Small Cell Lung Cancer (NSCLC) Metastatic Patients [NA]
Clinical trial LUNG-05 is investigating chemotherapy effectiveness for metastatic non-small cell lung cancer and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Radiotherapy Plus Anti-PD-1 Versus Anti-PD-1 Alone in ypTanyN⁺M0 NSCLC [Phase 2]
This is a Phase 2 trial comparing radiotherapy plus a PD-1 inhibitor versus PD-1 inhibitor alone in postoperative ypTanyN+M0 non-small cell …
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Chemotherapy Plus Pitavastatin Guided by Patient-Derived Tumor-like Cell Clusters in Refractory Non-Small Cell Lung Cancer [Phase 1]
Phase 1 trial evaluating chemotherapy plus pitavastatin guided by patient-derived tumor-like cell clusters in refractory non-small cell lung…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Universal CAR-T Cells (REVO-UWD-03) for Advanced Hepatocellular Carcinoma and Lung Cancer [EARLY_Phase 1]
Early-phase clinical trial update for universal CAR-T cells REVO-UWD-03 in advanced hepatocellular carcinoma and non-small cell lung cancer,…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Analysis of PD-L1, TMB, MSI and ctDNA Dynamics to Predict and Monitor Response to Immunotherapy in Metastatic Cancer.
A clinical trial is evaluating biomarkers PD-L1, tumor mutational burden, MSI, and ctDNA to predict and monitor response to immunotherapy in…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Trametinib and Pembrolizumab in Treating Patients With Recurrent Non-small Cell Lung Cancer That Is Metastatic, Unresectable, or Locally Advanced [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the combination of trametinib and pembrolizumab in patients with recurrent or advanced non-small cell …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Sacituzumab Tirumotecan Plus Third-Generation TKI With/Without Radiotherapy for EGFR-Mutant NSCLC Brain Metastases [Phase 2]
Phase 2 clinical trial update exploring Sacituzumab Tirumotecan with or without radiotherapy for EGFR-mutant non-small cell lung cancer with…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM005 in Patients With Advanced Solid Tumors [Phase 1]
DM005 is being studied in a Phase 1 trial for patients with advanced solid tumors, including non-small-cell lung cancer and head and neck sq…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nelmastobart in Combination With Docetaxel in Non Small Cell Lung Cancer [Phase 2]
This clinical trial update notes a Phase 2 study of Nelmastobart in combination with docetaxel for non-small cell lung cancer, currently rec…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: SL-28 for Advanced Solid Tumours [Phase 1, Phase 2]
Clinical trial update for SL-28 in advanced solid tumours across multiple indications; the Phase 1/Phase 2 study is currently not yet recrui…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study Evaluating Neoadjuvant Chemotherapy, Concurrent Chemoradiotherapy Combined With Dual Immune Checkpoint Blockade in Patients With Locally Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating neoadjuvant chemotherapy with concurrent chemoradiotherapy plus dual immune checkpoint blockade in locally advanced…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Radiation During Osimertinib Treatment: a Safety and Efficacy Cohort Study [Phase 2]
A Phase 2 cohort study evaluating the safety and efficacy of radiation therapy given during Osimertinib treatment in patients with EGFR-posi…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion [Phase 1, Phase 2]
This early-phase study investigates intrapleural administration of toluene sulfonamide in patients with malignant pleural effusions, includi…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety Trial of Antimicrobial Therapy and Precision Radiation Therapy in Patients With Oligoprogressive Non-small Cell Lung Cancer [Phase 1]
A Phase 1 clinical trial exploring safety of combining antimicrobial therapy with precision radiation therapy for oligoprogressive, early-st…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint Inhibitors [Phase 2]
ClinicalTrials.gov update for QUILT-3.055, a Phase 2 study of combination immunotherapies in patients who previously received immune checkpo…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of LY4170156 in Participants With Selected Advanced Solid Tumors [Phase 1]
An early-phase study evaluating LY4170156 in selected advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Glecirasib Combined With Ivonescimab for First-line Treatment of KRAS G12C-mutated NSCLC [Phase 1, Phase 2]
Clinical trial update indicates a first-line study of Glecirasib plus Ivonescimab for KRAS G12C-mutated non-small cell lung cancer, currentl…